In the “you can’t make this stuff up” and cowinkydink categories, we learn from NBC Boston that a primary superspreader event for Covid-19 spewed forth from a international biotechnology company’s executive conference held on Feb. 26 and 27 at the Boston Marriott Long Wharf. The event, held by megafirm Biogen (NASDAQ: BIIB), led to about 20,000 cases, according to a new study.
When executives who attended the conference flew home to Europe, Asia and states across the U.S., these superspreaders infected their families and coworkers, seeding clusters of outbreaks. Also by sheer cowinkydink, the study revealed a “unique feature” of the Biogen cohort’s cases: Nearly all were mild and didn’t require hospitalization. Whodathunk?
This degree of illness proves in spades what a scam this all is.
MIT Tech Review covered the work of researchers at Stanford University who found a much larger number of people are infected with Covid-19 than reported, meaning that the death rate is much, much lower than we’ve been told. In fact, MIT Tech Review had to admit that the actual death rate is likely under 0.2%, which means its about as “dangerous” as the common flu.
Hospitalizations and deaths among the young are almost nonexistent. Out of 70,000 students reported to have tested positive for COVID-19 at U.S. universities, only three were hospitalized as of Oct. 5. None have died.
A statistician and Chinese citizen who was working in Massachusetts for Biogen, Inc. — the sponsor of the infamous Boston meeting that became an epicenter for the U.S. COVID-19 outbreak — is being investigated in Beijing for allegedly flying home to her native China while sick, not disclosing her exposure to coronavirus to the airline, and covering up her fever with drugs to fool airport screeners, according to reports in Chinese-based media.
Chinese authorities are considering whether Jie Li, of Belmont, who was associate director of biostatistics for Biogen, broke the law by impeding the prevention of infectious disease, according to government-controlled Chinese media. Li, 37, is a Chinese citizen from Chongqing.
A large percentage of these superspreader cases stem from local homeless individuals taking refuge in shelters and the employees who worked there, a finding that Pardis Sabeti, a computational biologist at the Broad Institute and one of the lead researchers on the study, calls jaw-dropping.
“It was the realization that these events really affect the most vulnerable among us,” Sabeti told The Post. It’s unknown how the virus jumped from the conference to those living on the streets of Boston.
Takeaway: No shit, Sherlock.
Just because Biogen helped contribute to a nationwide outbreak of Covid-19 is no reason the company shouldn’t try to profit from it.
Biogen has helped build a COVID-19 biobank, a new consortium in partnership with The Broad Institute of MIT and Harvard and Partners HealthCare. The biobank, comprised of blood samples and other medical and biological data, will help researchers better understand the biology and behavior of the coronavirus.
The biobank is structured to protect the privacy of Biogen employees who take part.
“Biogen will have the same level of access to the Biobank as researchers around the world, which means it will not have access to identifiable information.”
Naturally, this study was parlayed into a leading role for Biogen in the field of contract tracing. Collecting data on Covid-19 and tracing promises to be commercially profitable, with almost all government and institutional levels getting involved.
In a recent Fox News interview, UCLA epidemiologist Dr. Anne W. Ramoin mentioned that the Boston Biogen event spread Covid-19 across the United States.
She also said that DNA-sequenced contact tracing will be done on the virus that made its way into the White House. With that DNA sequencing data, they can narrow down the source of contact. She said doing this is essential not just for public health, but also for national security.
Biogen also teamed with Satanist par excellence Bill Gates on several projects, including antibody research, particularly in the pharma manufacturing arena. This research is also focused on coronavirus antibodies.
In 2017, Biogen faced Congressional criticism for price gouging involving it’s multiple sclerosis drugs.
On a personal note, I have a head cold and have been sniffling over the last eight days. I had sweats but no significant fever. Friday, I experienced one night of hard coughing, which seemed to alleviate the irritant. Is this Covid-1984? I don’t know. I do have type A blood which is the catch type. Given that there’s an alleged big outbreak here in Prague — the highest in Europe – maybe so. Regardless I can say it’s really no different from 50 other colds I’ve had in my life.
Per the Stanford research, I now think this coronavirus is widespread and largely benign, except for the very elderly, those with comorbidities, those who’ve damaged their lungs by smoking or people with diabetes and immune deficiencies. I could run down and pay $100 for a test, but that would just feed the meaningless case statistics and hysteria. The odds are high that you will be exposed in these outbreak centers regardless. I don’t believe they are necessarily lying about the “cases”, just the implications.
I’m 69, so I’m treating this conservatively and more diligently, even if it is just a common cold rather than the ‘rona. More importantly there are also a bunch of old folks holed up in my building, so I’m laying low, using a mask in the building, washing my hands, wearing gloves in the elevator, and while using building door handles, bagging garbage, and not bothering with recycling, and pretty much staying home until my cold is gone. The real risk to these old-timer neighbors is the overreaction, being abandoned and left alone by the Covid tyrants in some old folk’s home or hospital.